Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
The pill times 2: What every woman with multiple sclerosis should know.
The gut microbiota and its correlations with the central nervous system disorders.
Neuromyelitis optica: clinical manifestations and neuroimaging features.
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Pain and multiple sclerosis: pathophysiology and treatment.
Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Assessing upper limb function in multiple sclerosis.
Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis.
Structure of the first sphingosine 1-phosphate receptor.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »